Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Technology Stocks : DWCH-Datawatch Worth Watching! -- Ignore unavailable to you. Want to Upgrade?

To: Kevin C. who wrote (416)	4/14/1998 8:39:00 PM
From: sharky18	Read Replies (1) \| Respond to of 462

This quarter, should be a little worse than lst quarter. Of course the numbers do not include any virex sales. The overall play is the next two quarters, which shoul show strong sales from monarch. I expect revenues of 6.3 to 6.6 million, and a loss of 10 cents. Thats expected. We need to see some IBM sales for monarch, over the next 3 to 6 mo. thats why the stock is worth 6 to 7. not because, of this quarters results! good luck all. Im a buyer up to 3.50.

To: Kevin C. who wrote (416)	4/20/1998 5:35:00 PM
From: Kevin C.	Read Replies (1) \| Respond to of 462

They're Trying. Datawatch To Resell ServiceSoft's Intelligent Self-Service Products and Integrate Them Into Their Q-Support(tm) Help Desk Application Q-Flow Change Management Module Integrates with Q-Support Help Desk and Asset Management Solution Datawatch Corporation Names Dr. Terry W. Potter to Board of Directors (See news at top of thread for full stories) If anything I like the velocity of change. Now I need the stock price to rise. I hope the Virex sale, with the loss of revenues, translated into significant cost savings. Perhaps this quarter will be good if the marketing initiatives had time to help. The time has been short but we could be surprised. I do like their efforts for the near future. They usually report about a month out, although I have not heard a date yet. Kevin.